Home / Poster / Application of Physiologically Based Pharmacokinetic (PBPK) Modelling to Predict the Pharmacokinetics of Alfentanil and Midazolam in Preterm Neonates

Poster

Application of Physiologically Based Pharmacokinetic (PBPK) Modelling to Predict the Pharmacokinetics of Alfentanil and Midazolam in Preterm Neonates

Application of Physiologically Based Pharmacokinetic (PBPK) Modelling to Predict the Pharmacokinetics of Alfentanil and Midazolam in Preterm Neonates

Recommended for you

How Model-informed drug development rescue projects from a risky situation

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

© 2025 Certara. All Rights Reserved. | Privacy policy